Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-17-034333

President & CEO sold 15,000 shares at $37.21 ($558,150)

  • President & CEO acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Abdun-Nabi Daniel · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-31 Exercise or conversion : show line 1 in the form +15,000 $22.03 $330,450 219,134 D
2017-08-31 Sale : show line 2 in the form −15,000 $37.21 $558,150 204,134 D
Open-market sales · 15,000 sh · avg $37.21 · $558,150

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-08-31 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −15,000 26,508 D
Loading xslF345X03/doc1.xml…